“Prime-Boost Interval Matters: A Randomized Phase 1 Study To Identify The Minimum Interval Necessary To Observe The H5 Dna Influenza Vaccine Priming Effect.”. J Infect Dis 208 (3). J Infect Dis: 418-22. doi:10.1093/infdis/jit180.
. 2013. “Dna Priming And Influenza Vaccine Immunogenicity: Two Phase 1 Open Label Randomised Clinical Trials.”. Lancet Infect Dis 11 (12). Lancet Infect Dis: 916-24. doi:10.1016/S1473-3099(11)70240-7.
. 2011.